Latest Articles

Article Type

You have access
Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors
Michele Visentin, Angelo Torozi, Zhibo Gai, Stephanie Häusler, Chao Li, Christian Hiller, Peter H. Schraml, Holger Moch and Gerd A. Kullak-Ublick

Drug Metabolism and Disposition August 2018, 46 (8) 1129-1136; DOI: https://doi.org/10.1124/dmd.118.081091
You have access
Age-Related Changes in Expression and Activity of Human Hepatic Mitochondrial Glutathione Transferase Zeta1
Guo Zhong, Margaret O. James, Marci G. Smeltz, Stephan C. Jahn, Taimour Langaee, Pippa Simpson and Peter W. Stacpoole

Drug Metabolism and Disposition August 2018, 46 (8) 1118-1128; DOI: https://doi.org/10.1124/dmd.118.081810
You have access
CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712
Sarah M. Glass, Cydney M. Martell, Alexandria K. Oswalt, Victoria Osorio-Vasquez, Christi Cho, Michael J. Hicks, Jacqueline M. Mills, Rina Fujiwara, Michael J. Glista, Sharat S. Kamath and Laura Lowe Furge

Drug Metabolism and Disposition August 2018, 46 (8) 1106-1117; DOI: https://doi.org/10.1124/dmd.117.079871
You have access
Development and Characterization of a Human Hepatocyte Low Intrinsic Clearance Assay for Use in Drug Discovery
Paul Lancett, Beth Williamson, Patrick Barton and Robert J. Riley

Drug Metabolism and Disposition August 2018, 46 (8) 1169-1178; DOI: https://doi.org/10.1124/dmd.118.081596
You have access
S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy
Sherif M. Shoieb and Ayman O. S. El-Kadi

Drug Metabolism and Disposition August 2018, 46 (8) 1157-1168; DOI: https://doi.org/10.1124/dmd.118.082073
You have access
Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development
Sarah Dubaisi, Kathleen G. Barrett, Hailin Fang, Jorge Guzman-Lepe, Alejandro Soto-Gutierrez, Thomas A. Kocarek and Melissa Runge-Morris

Drug Metabolism and Disposition August 2018, 46 (8) 1146-1156; DOI: https://doi.org/10.1124/dmd.118.081398
You have access
An Assessment of the In Vitro Inhibition of Cytochrome P450 Enzymes, UDP-Glucuronosyltransferases, and Transporters by Phosphodiester- or Phosphorothioate-Linked Oligonucleotides
Faraz Kazmi, Phyllis Yerino, Chase McCoy, Andrew Parkinson, David B. Buckley and Brian W. Ogilvie

Drug Metabolism and Disposition August 2018, 46 (8) 1066-1074; DOI: https://doi.org/10.1124/dmd.118.081729
Open Access
Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity
Meetal Solanki, Amy Pointon, Barry Jones and Karl Herbert

Drug Metabolism and Disposition August 2018, 46 (8) 1053-1065; DOI: https://doi.org/10.1124/dmd.117.078964
You have access
Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition
Hong Shen, Lisa Christopher, Yurong Lai, Jiachang Gong, Hamza Kandoussi, Samira Garonzik, Vidya Perera, Tushar Garimella and W. Griffith Humphreys

Drug Metabolism and Disposition August 2018, 46 (8) 1075-1082; DOI: https://doi.org/10.1124/dmd.118.081125
You have access
Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Cellular Protection and Transport of Methylated Arsenic Metabolites Differs between Human Cell Lines
Mayukh Banerjee, Gurnit Kaur, Brayden D. Whitlock, Michael W. Carew, X. Chris Le and Elaine M. Leslie

Drug Metabolism and Disposition August 2018, 46 (8) 1096-1105; DOI: https://doi.org/10.1124/dmd.117.079640

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals